SECO International, LLC
OCU410 gene therapy shows potential in geographic atrophy - Healio
Written on 10/27/2026
...
Academy
of
Ophthalmology
meeting. The trial evaluated OCU410 (Ocugen) subretinal gene
therapy
in patients with
geographic atrophy
. The one-time ...
Read full article